Your browser doesn't support javascript.
loading
Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle.
Deguil, Julie; Auffret, Alexandra; Schenker, Esther; Aujard, Fabienne; Lamberty, Yves; Bartrès-Faz, David; Blin, Olivier; Micallef, Joëlle; Richardson, Jill C; Bordet, Régis.
Affiliation
  • Bordet R; Department of Pharmacology, University Lille Nord de France, Lille, France. regis.bordet@univ-lille2.fr.
CNS Neurol Disord Drug Targets ; 15(7): 754-5, 2016.
Article in En | MEDLINE | ID: mdl-27549167
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Drug Discovery / Alzheimer Disease Type of study: Diagnostic_studies Limits: Humans Language: En Journal: CNS Neurol Disord Drug Targets Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Drug Discovery / Alzheimer Disease Type of study: Diagnostic_studies Limits: Humans Language: En Journal: CNS Neurol Disord Drug Targets Journal subject: NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article